By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Ivermectin (topical) (monograph)
Drugs

Ivermectin (topical) (monograph)

https://themeditary.com/drug/ivermectin-topical-monograph-6262.html
Medically Reviewed by Glamora Samuels, MD TheMediTary.Com | Reviewed: Aug 13, 2023  Additional Content by TheMediTary.Com

Generic name: sklice

Availability: Rx and/or otc

Pregnancy & Lactation: Risk data available

Brand names: Sklice, Soolantra

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

What is Ivermectin (topical) (monograph)?

Introduction

Pediculicide; avermectin derivative.

Uses for Ivermectin (Topical)

Pediculosis

Topical treatment of pediculosis capitis (head lice infestation) in adults and children ≥6 months of age.

AAP and others usually recommend topical treatment with OTC preparation of permethrin 1% or pyrethrins with piperonyl butoxide for initial treatment; other topical pediculicides (e.g., malathion 0.5%, benzyl alcohol 5%, spinosad 0.9%) recommended if OTC preparations ineffective or permethrin or pyrethrin resistance suspected. Oral ivermectin recommended as an alternative for infestations not responding to or resistant to topical agents.

Ivermectin (Topical) Dosage and Administration

General

Measures to Avoid Reinfestation and Transmission of Lice

  • To avoid reinfestation or transmission of lice, most experts recommend that clothing, hats, bed linen, and towels worn or used by infested individual during the 2 days prior to treatment be decontaminated (machine-washed in hot water and dried in a hot dryer).

  • Items that cannot be laundered can be dry-cleaned or sealed in a plastic bag for 2 weeks.

  • Decontaminate combs, brushes, and hair clips used by infested individual by soaking in hot water (>54°C) for 5–10 minutes.

  • Thoroughly vacuum car seats, upholstered furniture, and floors of rooms inhabited by infested individual. Fumigation of living areas not necessary.

  • Evaluate other family members and close contacts of infested individual and treat if lice infestation present. Some clinicians suggest treating family members who share a bed with infested individual, even if no live lice found on this family member. Ideally, treat all infested household members and close contacts at same time.

  • A fine-toothed or nit comb may be used to remove any remaining nits (eggs) or nit shells from hair. Some clinicians do not consider nit removal necessary since only live lice can be transmitted, but recommend it for aesthetic reasons and to decrease diagnostic confusion and unnecessary retreatment. Other clinicians recommend removal of nits (especially those within 1 cm of scalp) to decrease risk of reinfestation since no pediculicide is 100% ovicidal and potentially viable nits may remain on hair after treatment. Although many schools will not allow children with nits to attend, AAP and other experts consider these no-nit policies excessive.

Administration

Topical Administration

Apply topically to scalp and hair as 0.5% lotion.

For external use only. Do not administer orally or intravaginally; do not apply topically to eyes.

Apply to dry scalp and hair in amount sufficient to thoroughly coat hair and scalp. Leave lotion on hair and scalp for 10 minutes, then thoroughly rinse off with warm (not hot) water. Minimize exposing other areas of skin by performing rinse at a sink (rather than in shower or bath).

Avoid contact with eyes. If contact with eyes occurs, immediately flush with water.

Available in single-use tube; discard any unused portion.

Supervise pediatric patients during lotion application; an adult should apply and rinse the lotion for the child. (See Inadvertent Ingestion in Pediatric Patients under Cautions.)

Wash hands after applying the lotion.

Dosage

Pediatric Patients

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Infants and children ≥6 months of age: Manufacturer recommends single application.

Apply to dry hair and scalp in an amount sufficient to completely coat hair and scalp. After 10 minutes, thoroughly rinse lotion off with water. (See Administration under Dosage and Administration.)

Adults

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Manufacturer recommends single application.

Apply to dry hair and scalp in an amount sufficient to completely coat hair and scalp. After 10 minutes, thoroughly rinse lotion off with water. (See Administration under Dosage and Administration.)

Prescribing Limits

Pediatric Patients

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Infants and children ≥6 months of age: Do not exceed single tube of lotion (120 mL).

Adults

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Do not exceed single tube of lotion (120 mL).

Special Populations

No special population dosage recommendations.

Detailed Ivermectin topical dosage information

Warnings

Contraindications

  • No known contraindications.

Warnings/Precautions

Inadvertent Ingestion in Pediatric Patients

To prevent ingestion in pediatric patients, use only under direct supervision of an adult. (See Pediatric Use under Cautions.)

Specific Populations

Pregnancy

Category C.

Lactation

Not known whether distributed into milk after topical application. Use with caution in nursing women.

Pediatric Use

Safety and efficacy not established in infants <6 months of age; greater skin surface area to body mass ratio and potentially immature skin barrier in this age group may increase systemic absorption and toxicity. Use only in infants and children ≥6 months of age.

Keep out of the reach of children; use only under direct supervision of an adult.

Geriatric Use

Insufficient experience in adults ≥65 years of age to determine whether geriatric patients respond differently than younger adults.

Common Adverse Effects

Conjunctivitis, ocular hyperemia, eye irritation, dandruff, dry skin, burning skin sensation.

How should I use Ivermectin (topical) (monograph)

General

Measures to Avoid Reinfestation and Transmission of Lice

  • To avoid reinfestation or transmission of lice, most experts recommend that clothing, hats, bed linen, and towels worn or used by infested individual during the 2 days prior to treatment be decontaminated (machine-washed in hot water and dried in a hot dryer).

  • Items that cannot be laundered can be dry-cleaned or sealed in a plastic bag for 2 weeks.

  • Decontaminate combs, brushes, and hair clips used by infested individual by soaking in hot water (>54°C) for 5–10 minutes.

  • Thoroughly vacuum car seats, upholstered furniture, and floors of rooms inhabited by infested individual. Fumigation of living areas not necessary.

  • Evaluate other family members and close contacts of infested individual and treat if lice infestation present. Some clinicians suggest treating family members who share a bed with infested individual, even if no live lice found on this family member. Ideally, treat all infested household members and close contacts at same time.

  • A fine-toothed or nit comb may be used to remove any remaining nits (eggs) or nit shells from hair. Some clinicians do not consider nit removal necessary since only live lice can be transmitted, but recommend it for aesthetic reasons and to decrease diagnostic confusion and unnecessary retreatment. Other clinicians recommend removal of nits (especially those within 1 cm of scalp) to decrease risk of reinfestation since no pediculicide is 100% ovicidal and potentially viable nits may remain on hair after treatment. Although many schools will not allow children with nits to attend, AAP and other experts consider these no-nit policies excessive.

Administration

Topical Administration

Apply topically to scalp and hair as 0.5% lotion.

For external use only. Do not administer orally or intravaginally; do not apply topically to eyes.

Apply to dry scalp and hair in amount sufficient to thoroughly coat hair and scalp. Leave lotion on hair and scalp for 10 minutes, then thoroughly rinse off with warm (not hot) water. Minimize exposing other areas of skin by performing rinse at a sink (rather than in shower or bath).

Avoid contact with eyes. If contact with eyes occurs, immediately flush with water.

Available in single-use tube; discard any unused portion.

Supervise pediatric patients during lotion application; an adult should apply and rinse the lotion for the child. (See Inadvertent Ingestion in Pediatric Patients under Cautions.)

Wash hands after applying the lotion.

Dosage

Pediatric Patients

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Infants and children ≥6 months of age: Manufacturer recommends single application.

Apply to dry hair and scalp in an amount sufficient to completely coat hair and scalp. After 10 minutes, thoroughly rinse lotion off with water. (See Administration under Dosage and Administration.)

Adults

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Manufacturer recommends single application.

Apply to dry hair and scalp in an amount sufficient to completely coat hair and scalp. After 10 minutes, thoroughly rinse lotion off with water. (See Administration under Dosage and Administration.)

Prescribing Limits

Pediatric Patients

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Infants and children ≥6 months of age: Do not exceed single tube of lotion (120 mL).

Adults

Pediculosis
Pediculosis Capitis (Head Lice Infestation)
Topical

Do not exceed single tube of lotion (120 mL).

Special Populations

No special population dosage recommendations.

Detailed Ivermectin topical dosage information
Ivermectin (topical) (monograph) Dosage information (more detail)

More about Ivermectin (topical) (monograph) (Sklice)

Dosage information
Ivermectin (topical) (monograph) Side Effects
During pregnancy
Ivermectin Cream Prescribing Information
Drug images
Side effects
Breastfeeding Warnings
Drug class: Drugs

Patient resources

Ivermectin Cream
Ivermectin Lotion

Related treatment guides

Rosacea
Head Lice
Share this Article
Contents
Uses Warnings Before Taking Dosage Side effects Interactions
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by